Gilead to buy biotech firm Ouro Medicines in over $2 billion deal


March 23 (Reuters) – ‌Gilead ‌Sciences said ​on Monday it ‌would ⁠buy privately ⁠held ​biotech ​firm ​Ouro ‌Medicines in a deal ‌worth ​up ​to $2.18 ​billion.

(Reporting ‌by Mariam ​Sunny ​in ​Bengaluru; ‌Editing by ​Shilpi ​Majumdar)



Source link

  • Related Posts

    NTSB says flight data recorder was recovered from plane after collision at LaGuardia 

    IE 11 is not supported. For an optimal experience visit our site on another browser. Sen. Markwayne Mullin confirmed as new head of DHS 03:31 Now Playing NTSB says flight…

    Asian shares mostly rebound after Trump hints at a possible end to the Iran war

    TOKYO (AP) — Asian benchmarks mostly rebounded Tuesday, echoing cautious relief that swept through Wall Street after President Donald Trump said the United States has talked with Iran about a…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Hasan Piker Defends Upscale Lodging During Humanitarian Mission in Cuba

    Tonga PM welcomes US deal to explore deep-sea minerals amid environmental concerns | Pacific leaders: in their words

    Tonga PM welcomes US deal to explore deep-sea minerals amid environmental concerns | Pacific leaders: in their words

    Polymarket’s Coming-Out Party in Washington Was a Disaster

    Polymarket’s Coming-Out Party in Washington Was a Disaster

    Football Black List 2025: Jess Carter, Eberechi Eze and Alex Iwobi named

    Football Black List 2025: Jess Carter, Eberechi Eze and Alex Iwobi named

    Senate confirms Mullin as Homeland Security secretary

    Senate confirms Mullin as Homeland Security secretary

    NTSB says flight data recorder was recovered from plane after collision at LaGuardia 

    NTSB says flight data recorder was recovered from plane after collision at LaGuardia